FDA to let AstraZeneca's coronavirus vaccine trials resume in the US

More than a month after the global trial pause and long after international trials resumed, FDA regulators will finally let Oxford's trials can restart in the US, according to the Wall Street Journal.

from Health News | Mail Online https://ift.tt/31wUnjx